Dr Reddy’s Gets USFDA Tentative Nod for Generic Lenacapavir
Dr Reddy’s wins USFDA tentative approval under PEPFAR for generic twice-yearly lenacapavir for HIV prevention, with first supplies due before end-2026.
LENACAPAVIR
Dr Reddy’s wins USFDA tentative approval under PEPFAR for generic twice-yearly lenacapavir for HIV prevention, with first supplies due before end-2026.
